R3-TA 20mg – Research Vial

R3-TA is supplied by CLINICORE Peptides in a single vial format as a white to off white lyophilised powder. This R3-TA research peptide listing provides a clear specification set to support laboratory documentation, reference preparation, and method evaluation within a controlled research setting.

This section provides R3-TA handling and solubility information for laboratory workflows. Handle using appropriate laboratory PPE and aseptic technique where required. Avoid unnecessary exposure to ambient humidity and minimise time at room temperature during transfers.

R3-TA peptide powder is soluble in sterile water or bacteriostatic water for research use only. Gentle swirling is recommended. Do not shake aggressively.

These R3-TA storage guidelines apply to lyophilised research peptides. Store lyophilised material at -20°C, protected from light and moisture.

Following reconstitution, store at 2–8°C and use within 14 days. Do not freeze thaw repeatedly. Where aliquoting is required, use sterile containers and validated storage conditions.

This R3-TA research peptide is supplied strictly for laboratory research purposes only. It is not intended for human or veterinary use and is not approved for diagnostic, therapeutic, or medical applications. Use only in accordance with applicable regulations and institutional laboratory safety procedures.

CLINICORE Peptides applies a controlled specification led approach to research peptide supply. Each R3-TA vial is presented with defined identity and quality markers including stated content, appearance, and reported analytical purity to support consistent laboratory documentation and reproducible handling.

If you require additional documentation for internal QC records, contact the CLINICORE team prior to use so we can advise what is available for your order. You can also view related R3-TA research peptides within the R3-TA collection.